Direct growth‐inhibitory effects of prostaglandin E2 in pancreatic cancer cells in vitro through an EP4/PKA‐mediated mechanism
暂无分享,去创建一个
G. Eibl | E. Rozengurt | J. Sinnett-Smith | D. Dawson | Hui-Hua Chang | J. Hines | A. Schmidt | Steve Young | Joe O. Hines
[1] S. H. Young,et al. Prostaglandin E2 activates the mTORC1 pathway through an EP4/cAMP/PKA- and EP1/Ca2+-mediated mechanism in the human pancreatic carcinoma cell line PANC-1. , 2015, American journal of physiology. Cell physiology.
[2] Soken Tsuchiya,et al. Prostaglandin E2-induced inflammation: Relevance of prostaglandin E receptors. , 2015, Biochimica et biophysica acta.
[3] Huamin Wang,et al. Combined Targeting of STAT3/NF-κB/COX-2/EP4 for Effective Management of Pancreatic Cancer , 2014, Clinical Cancer Research.
[4] Aune Moro,et al. miR-143 decreases COX-2 mRNA stability and expression in pancreatic cancer cells. , 2013, Biochemical and biophysical research communications.
[5] K. Iwatsubo,et al. The Prostanoid EP4 Receptor and Its Signaling Pathway , 2013, Pharmacological Reviews.
[6] Yanping Zhang,et al. Increased Th17 Cells in the Tumor Microenvironment Is Mediated by IL-23 via Tumor-Secreted Prostaglandin E2 , 2013, The Journal of Immunology.
[7] R. Hwang,et al. Prostaglandin E2 Regulates Pancreatic Stellate Cell Activity Via the EP4 Receptor , 2013, Pancreas.
[8] R. Hwang,et al. PGE2 Regulates Pancreatic Stellate Cell Activity Via The EP4 Receptor , 2013 .
[9] X. Dai,et al. Involvement of COX-2/PGE2 Pathway in the Upregulation of MMP-9 Expression in Pancreatic Cancer , 2011, Gastroenterology research and practice.
[10] Hiroki Takahashi,et al. Cyclooxygenase-2 Confers Growth Advantage to Syngeneic Pancreatic Cancer Cells , 2011, Pancreas.
[11] Jonathan C. King,et al. Loss of 15-Hydroxyprostaglandin Dehydrogenase Increases Prostaglandin E2 in Pancreatic Tumors , 2010, Pancreas.
[12] D. Fitzgerald,et al. Proneoplastic effects of PGE2 mediated by EP4 receptor in colorectal cancer , 2009, BMC Cancer.
[13] V. Go,et al. Expression Analysis of the Prostaglandin E2 Production Pathway in Human Pancreatic Cancers , 2008, Pancreas.
[14] H. Reber,et al. Mononuclear cell-derived interleukin-1 beta confers chemoresistance in pancreatic cancer cells by upregulation of cyclooxygenase-2. , 2008, Surgery.
[15] H. Reber,et al. Delayed progression of pancreatic intraepithelial neoplasia in a conditional Kras(G12D) mouse model by a selective cyclooxygenase-2 inhibitor. , 2007, Cancer research.
[16] J. Gutkind,et al. G-protein-coupled receptors and cancer , 2007, Nature Reviews Cancer.
[17] Anne E Carpenter,et al. CellProfiler: image analysis software for identifying and quantifying cell phenotypes , 2006, Genome Biology.
[18] A. C. Williams,et al. Mediators of PGE2 synthesis and signalling downstream of COX-2 represent potential targets for the prevention/treatment of colorectal cancer. , 2006, Biochimica et biophysica acta.
[19] M. Pino,et al. Prostaglandin E2 drives cyclooxygenase 2 expression via cyclic AMP response element activation in human pancreatic cancer cells , 2005, Cancer biology & therapy.
[20] D. Bar-Sagi,et al. Ras Oncogene and Inflammation: Partners in Crime , 2005, Cell cycle.
[21] L. Boros,et al. Growth stimulation of COX-2-negative pancreatic cancer by a selective COX-2 inhibitor. , 2005, Cancer research.
[22] M. Hull,et al. Prostaglandin EP receptors: targets for treatment and prevention of colorectal cancer? , 2004, Molecular cancer therapeutics.
[23] H. Reber,et al. PGE(2) is generated by specific COX-2 activity and increases VEGF production in COX-2-expressing human pancreatic cancer cells. , 2003, Biochemical and biophysical research communications.
[24] J. Regan,et al. Prostanoid receptors and phosphatidylinositol 3-kinase: a pathway to cancer? , 2003, Trends in pharmacological sciences.
[25] M. Wente,et al. The Selective Cyclooxygenase-2 Inhibitor Nimesulide Induces Apoptosis in Pancreatic Cancer Cells Independent of COX-2 , 2003, Pancreas.
[26] M. Dohadwala,et al. Autocrine/Paracrine Prostaglandin E2 Production by Non-small Cell Lung Cancer Cells Regulates Matrix Metalloproteinase-2 and CD44 in Cyclooxygenase-2-dependent Invasion* , 2002, The Journal of Biological Chemistry.
[27] P. Stork,et al. Crosstalk between cAMP and MAP kinase signaling in the regulation of cell proliferation. , 2002, Trends in cell biology.
[28] B. Evers,et al. Inflammation and the development of pancreatic cancer. , 2002, Surgical oncology.
[29] C. Coscia,et al. Diversity of G Protein-Coupled Receptor Signaling Pathways to ERK/MAP Kinase , 2002, Neurosignals.
[30] A. Levine,et al. Prostaglandin E2 Stimulates Prostatic Intraepithelial Neoplasia Cell Growth through Activation of the Interleukin-6/GP130/STAT-3 Signaling Pathway , 2002 .
[31] N. Rivard,et al. cAMP protection of pancreatic cancer cells against apoptosis induced by ERK inhibition. , 2001, Biochemical and biophysical research communications.
[32] M. Kay Washington,et al. Prostaglandin E2 Increases Growth and Motility of Colorectal Carcinoma Cells* , 2001, The Journal of Biological Chemistry.
[33] L. Heasley,et al. Autocrine and paracrine signaling through neuropeptide receptors in human cancer , 2001, Oncogene.
[34] E. Mccleskey,et al. Role of Phosphoinositide 3-Kinase and Endocytosis in Nerve Growth Factor-Induced Extracellular Signal-Regulated Kinase Activation via Ras and Rap1 , 2000, Molecular and Cellular Biology.
[35] F. Sinicrope,et al. Increased cyclooxygenase-2 expression in human pancreatic carcinomas and cell lines: growth inhibition by nonsteroidal anti-inflammatory drugs. , 1999, Cancer research.
[36] T. Fahey,et al. Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer. , 1999, Cancer research.
[37] A. Ristimäki,et al. Expression of cyclooxygenase-2 in human lung carcinoma. , 1998, Cancer research.
[38] D. Scollard,et al. Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer. , 1998, Journal of the National Cancer Institute.
[39] Y. Sugimoto,et al. Molecular mechanisms of diverse actions of prostanoid receptors. , 1995, Biochimica et biophysica acta.
[40] M. Kondo,et al. Expression of cyclooxygenase-1 and -2 in human colorectal cancer. , 1995, Cancer research.
[41] R. Coffey,et al. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. , 1994, Gastroenterology.
[42] M. Caron,et al. G-protein-coupled receptor genes as protooncogenes: constitutively activating mutation of the alpha 1B-adrenergic receptor enhances mitogenesis and tumorigenicity. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[43] Andre Kajdacsy-Balla,et al. Requirement of cyclooxygenase-2 expression and prostaglandins for human prostate cancer cell invasion , 2004, Clinical & Experimental Metastasis.
[44] H. Reber,et al. PGE(2) is generated by specific COX-2 activity and increases VEGF production in COX-2-expressing human pancreatic cancer cells. , 2003, Biochemical and biophysical research communications.
[45] E. Rozengurt,et al. Gastrointestinal peptide signalling in health and disease. , 2002, The European journal of surgery. Supplement. : = Acta chirurgica. Supplement.
[46] A. Levine,et al. Prostaglandin E(2) stimulates prostatic intraepithelial neoplasia cell growth through activation of the interleukin-6/GP130/STAT-3 signaling pathway. , 2002, Biochemical and biophysical research communications.
[47] D. Bostwick,et al. Over‐expression of cyclooxygenase‐2 in human prostate adenocarcinoma , 2000, The Prostate.
[48] L. Marnett,et al. Prostaglandin and thromboxane biosynthesis. , 1991, Pharmacology & therapeutics.